Insider Shareholders with Direct Ownership of Synaptogenix, Inc. (SNPX)
This section provides a comprehensive overview of the insiders with direct ownership of Synaptogenix, Inc. (SNPX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Synaptogenix, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
George Perry
Director |
40,000 | 0 | 40,000 $368,400 | 1 |
Jul 13, 2021
Added 50.0%
|
|
Daniel L. Alkon
President and CSO |
90,000 | 19,688 | 35,546 $327,378 | 3 |
Dec 16, 2022
Reduced 35.64%
|
|
Joshua Silverman
Executive Chairman |
141,919 | 35,780 | 26,681 $245,732 | 5 |
Jun 30, 2025
Reduced 38.59%
|
|
Bruce Bernstein
Director |
74,657 | 32,363 | 15,897 $146,411 | 4 |
Jun 30, 2025
Reduced 38.29%
|
|
Jonathan Schechter
Director |
66,575 | 28,880 | 14,035 $129,262 | 4 |
Jun 30, 2025
Reduced 38.08%
|
|
Robert Weinstein
Chief Financial Officer |
75,410 | 33,164 | 10,574 $97,386 | 4 |
Jun 30, 2025
Reduced 36.83%
|
|
William S. Singer
Director |
75,410 | 33,164 | 10,566 $97,312 | 4 |
Jun 30, 2025
Reduced 36.84%
|
|
Alan J Tuchman
Chief Medical Officer |
64,315 | 28,726 | 3,909 $36,001 | 4 |
Jun 30, 2025
Reduced 30.63%
|